AutoICD API

105496-4

Clinical

A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%

LOINC 6-Axis Classification

Component

A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%

Property

Find

Time Aspect

Pt

System

^Patient

Scale Type

Ord

Method Type

N/A

Details

Class

PHENX

Order/Observation

Observation

Short Name

Not in the expected range of benefit

Related Names

ChemoFindingFindingsNot in the expected range of benefitOrdinalPhenXPoint in timeQLQualQualitativeRandomRngeScreenStudy report

Frequently Asked Questions

What is LOINC code 105496-4?

LOINC code 105496-4 identifies "A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%". It measures A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50% in ^Patient.

What does 105496-4 measure?

This code measures A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50% in ^Patient. It belongs to the PHENX class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.